Affiliate disclosure: Some links below are affiliate links. If you sign up through one of these links, we may earn a commission at no extra cost to you. This does not influence our comparisons or recommendations.
If you're deciding between Ozempic and Mounjaro, price is probably a big factor. Both are powerful GLP-1 medications, but they're made by different companies with different pricing strategies. Your actual out-of-pocket cost depends on whether you have insurance, whether you qualify for discounts, and where you fill your prescription.
This guide breaks down exactly what each medication costs in 2026 so you can make a real comparison, not just look at list prices.
Quick verdict: For self-pay patients, Mounjaro vials are typically cheaper ($349–$499) than Ozempic ($499), but Ozempic wins if you can access the current introductory offer ($199/month). Insurance coverage varies widely and depends on your plan.
Ozempic's full retail price is approximately $978–$1,000 per month for a standard dose. This is what you'd pay without any discounts, insurance, or savings programs. Avoid this if possible.
Novo Nordisk, the manufacturer of Ozempic, offers a patient assistance program for self-pay eligible patients. The cost is a flat $499/month, and the medication ships directly to your home.
Who qualifies: You must be a U.S. resident without commercial insurance coverage (or your insurance doesn't cover the medication). You don't need to prove income, which makes this accessible to many people.
How to access: Go to Novo Nordisk's official website or ask your healthcare provider to enroll you.
If you have a discount card like GoodRx or SingleCare, Ozempic prices vary by pharmacy, but you're typically looking at $400–$600/month. This is cheaper than list price but more expensive than the manufacturer's direct program, so it's less optimal for uninsured patients.
With commercial insurance, Ozempic copayments can range from $25 to $200/month depending on your plan and deductible. Many insurance plans now cover Ozempic, but some require prior authorization or proof that you've tried other medications first.
As of 2026, Novo Nordisk is running an introductory offer: eligible new patients can get Wegovy oral semaglutide (same active ingredient as Ozempic) for $199/month for the first two months. After the promotion, pricing moves to $349–$499/month. This is technically a different formulation (oral vs. injectable), but if you're open to the pill version, it's an excellent entry price.
Mounjaro (tirzepatide), made by Eli Lilly, has a list price of $1,069–$1,079 per month for a standard one-month supply (four pens). Like Ozempic, this list price is rarely what anyone pays in practice.
Eli Lilly launched the Zepbound Self-Pay Journey Program (Zepbound is the weight-loss version of tirzepatide; Mounjaro is the diabetes version, but pricing is identical). When you buy directly through LillyDirect, you access vials instead of pre-filled pens, which dramatically reduces cost.
Dosing structure:
Why vials cost less: Pre-filled pens cost $900–$1,200/month because they're more convenient. Vials require you to draw the dose yourself with a syringe, which takes about 30 seconds and saves $200–$700/month. If you're comfortable with a needle, it's a no-brainer.
If you use a discount card like SingleCare, Mounjaro prices fall to around $800–$900/month. Better than list price, but more expensive than Lilly Direct, so less ideal if you don't have insurance.
Insurance coverage for Mounjaro varies widely. Some plans cover it; others exclude it or require extensive prior authorization. If your plan covers Mounjaro, your copay might be as low as $25–$150/month. If it doesn't cover it, you're paying out-of-pocket, and Lilly Direct becomes your best option.
Mounjaro wins. At $349/month for starting doses and $499/month for higher doses, Mounjaro vials beat Ozempic's $499/month flat rate. The difference is $150/month at the starting dose—that's $1,800/year.
Exception: If you qualify for Novo Nordisk's current $199/month promotion for Wegovy oral, that beats Mounjaro. But once the promotion ends, Mounjaro is cheaper.
Your plan determines the winner. Ask your insurance company what the copay is for each medication. It could be as low as $25–$50/month for either one if your plan covers it well. Some plans prefer one drug over the other and charge a lower copay as an incentive.
The most honest answer: costs are nearly identical for both medications when you account for real-world pricing through manufacturer programs ($349–$499/month for both). The choice should come down to efficacy, tolerability, and convenience, not price.
Based on real user experiences from 2026:
For uninsured patients, Mounjaro vials are typically $150–$200/month cheaper than Ozempic. For insured patients, the winner depends on your specific plan's coverage and copay structure. Don't assume one is cheaper without checking your actual insurance benefits—and always use manufacturer programs, not list prices, for self-pay options.
© 2026 Olson Coaches|About|Privacy Policy|Terms of Use|Contact|Pricing Guides
Guides:Cheapest GLP-1 Without Insurance·Ozempic vs Mounjaro Cost·Self-Pay Options
Tools:Medicare Bridge eligibility checker·Provider legitimacy checker
Medicare:Bridge Program 2026 guide
Affiliate Disclosure: We may earn commissions from partner links.
Sources: TrumpRx.gov, GoodRx, NovoCare, LillyDirect, CMS, KFF, FDA.gov